Agenus (AGEN) Invested Capital (2010 - 2026)
Agenus (AGEN) posted quarterly Invested Capital of $30.2 million for Q1 2026, up 4030.37% year-over-year from $731000.0 in Q1 2025, and down 32.39% quarter-over-quarter from $44.7 million in Q4 2025.
Analysis
Agenus (AGEN) Invested Capital (2010 - 2026) Analysis & Trends
Agenus' Invested Capital history runs 17 years deep, the most recent figure standing at $30.2 million for Q1 2026.
- In Q1 2026, Invested Capital rose 4030.37% year-over-year to $30.2 million; the TTM figure through Mar 2026 stood at $96.2 million (up 217.89% YoY), while the FY2025 annual figure was $44.7 million, up 1555.11% from the prior year.
- Invested Capital for Q1 2026 stood at $30.2 million, down from $44.7 million in the prior quarter.
- The five-year high for Invested Capital was $44.7 million in Q4 2025, with the low at $146000.0 in Q4 2023.
- The 5-year median for Invested Capital is $1.0 million (2023), against an average of $7.7 million.
- The sharpest annual moves came in 2023 and 2024: Invested Capital slumped 65.97% in 2023, then surged 5460.58% in 2024.
- Agenus' Invested Capital stood at $429000.0 in 2022, then plunged by 65.97% to $146000.0 in 2023, then jumped by 1747.95% to $2.7 million in 2024, then soared by 1555.11% to $44.7 million in 2025, then tumbled by 32.39% to $30.2 million in 2026.
- Business Quant data shows AGEN's Invested Capital at $30.2 million in Q1 2026, $44.7 million in Q4 2025, and $10.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Agenus | 343.02 Mn | 343.02 Mn | 34.52 Mn | -175.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -175.78 Mn |
| Mar 31, 2026 | -197.79 Mn |
| Dec 31, 2025 | -233.21 Mn |
| Sep 30, 2025 | -246.66 Mn |
| Jun 30, 2025 | -302.44 Mn |
| Mar 31, 2025 | -288.82 Mn |
| Dec 31, 2024 | -273.25 Mn |
| Sep 30, 2024 | -258.40 Mn |
| Jun 30, 2024 | -207.41 Mn |
| Mar 31, 2024 | -176.75 Mn |
| Dec 31, 2023 | -135.47 Mn |
| Sep 30, 2023 | -102.19 Mn |
| Jun 30, 2023 | -63.47 Mn |
| Mar 31, 2023 | -39.46 Mn |
| Dec 31, 2022 | -41.74 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 27.34 Mn |
| Mar 31, 2022 | 41.83 Mn |
| Dec 31, 2021 | 61.46 Mn |
| Sep 30, 2021 | 48.88 Mn |